References
1. Marshall DC, Jackson ME, Hattangadi-Gluth JA. Disclosure of Industry
Payments to Physicians: An Epidemiologic Analysis of Early Data From the
Open Payments Program. Mayo Clin Proc. 2016;91(1):84-96.
2. Tringale KR, Marshall D, Mackey TK, Connor M, Murphy JD,
Hattangadi-Gluth JA. Types and Distribution of Payments From Industry to
Physicians in 2015. JAMA. 2017;317(17):1774-1784.
3. Kusumi E, Murayama A, Kamamoto S, et al. Pharmaceutical payments to
Japanese certified hematologists: a retrospective analysis of personal
payments from pharmaceutical companies between 2016 and 2019.Blood Cancer Journal. 2022;12(4):54.
4. Putman MS, Goldsher JE, Crowson CS, Duarte-García A. Industry
Payments to Practicing US Rheumatologists, 2014–2019. Arthritis
& Rheumatology. 2021;73(11):2138-2144.
5. Annapureddy A, Murugiah K, Minges KE, Chui PW, Desai N, Curtis JP.
Industry Payments to Cardiologists. Circulation: Cardiovascular
Quality and Outcomes. 2018;11(12):e005016.
Figure 1. Monthly trend in general payments per physician and number of
physicians with payments between 2014 and 2020 in allergology and
clinical immunology in the United States